Back

Non-traditional lipid-inflammatory parameters and the development of prediabetes in middle-aged and older adults

30 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart: pharmacotherapy (3) Metabolic Syndrome, Insulin, Insulin Resistance ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Bingyan Yu

The University of Hong Kong, Hong Kong (Hong Kong)

3 More presentations in this session

Presentation thumbnail
Timing of statin treatment following diabetes diagnosis on risk of dementia: a nationwide study
Mr T. Ternhamar (Copenhagen, DK)
Abstract
Presentation thumbnail
Non-high-density lipoprotein cholesterol and residual cardiorenal risk in statin-treated patients with type 2 diabetes mellitus
Miss H. Sze (Hong Kong, HK)
Abstract
Presentation thumbnail
Low mediterranean diet adherence is associated with subclinical cardiovascular and endothelial dysfunction in well-controlled type 1 diabetes using hybrid closed-loop systems
Doctor I. Thymis (Athens, GR)
Abstract

Access the full session

Session thumbnail
Diabetes and the heart: pharmacotherapy (3)

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Incident CHD, residual risk and traditional cardiovascular risk factors in the community: role of lipid-inflammatory axis
1 September 2025
thumbnail
Congress Presentation
Prognostic significance of prediabetes in patients with acute myocardial infarction
21 March 2026
thumbnail
Congress Presentation
Causal pathways linking type 2 diabetes and glycemic traits to cerebrovascular outcomes: a comprehensive Mendelian randomization analysis
20 March 2026
thumbnail
Congress Presentation
Usefulness of cardiometabolic index for the estimation of diabetes risk among general population in rural China: a community-based study
17 April 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources